Evidence map›Paper›PMID 41272984›Full record

ArticleBrain and behavior2025

Differences in the Neural Substrate for Physical and Mental Quality of Life in Patients With Multiple Sclerosis.

Juichi Fujimori, Michiko Nei, Shu Umezawa, Tatsuro Misu, Ichiro Nakashima

Abstract read
In one paragraph

Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Juichi FujimoriDivision of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.ORCID 0000-0001-7170-7853
Michiko NeiNursing Bureau, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.
Shu UmezawaDepartment of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Tatsuro MisuDepartment of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Ichiro NakashimaDivision of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.ORCID 0000-0002-2612-8948

Funding

Japan Society for the Promotion of Science 24K10665LSI MedienceMinistry of Health, Labour and Welfare 24GC1010
6 · The paper itself

Abstract

introductionIdentifying patients with multiple sclerosis (PwMS) who primarily experience a gradual decline in mental rather than physical quality of life (QoL) is clinically significant, as QoL worsening may be underestimated. This study aims to compare the clinical characteristics and neural substrates of PwMS with predominantly reduced physical and mental QoL to distinguish between these patients.

methodsThis study included 75 PwMS, of whom 56 had relapsing-remitting multiple sclerosis (MS) and 19 had progressive MS. The Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) and Medical Outcomes Study Short Form-36 Health Survey were used to assess neuropsychological abnormalities and health-related QoL.

resultsPhysical and mental QoL were not correlated. In a subset of PwMS, cluster analysis revealed that either physical or mental QoL was primarily affected. Patients with reduced physical QoL (n = 9) were generally older, more likely to have a progressive disease course, and had higher EDSS scores. Imaging revealed reduced whole-brain and grey matter volumes, as well as bilateral cortical atrophy in the frontal lobes, specifically in the left rostral middle frontal cortex. In contrast, patients with reduced mental QoL (n = 19) had a relapsing-remitting disease course and elevated MSNQ scores. These patients exhibited an increased lesion load, T1 white matter hypointensity volume, and bilateral cortical atrophy in the temporal lobes, specifically in the right insula and left superior temporal cortex.

conclusionPwMS with predominantly reduced mental QoL exhibit distinct inflammatory changes that may contribute to disrupted connectivity and cortical atrophy in the lateral postcentral regions.

Indexed as

BrainMultiple SclerosisMultiple Sclerosis, Chronic ProgressiveMultiple Sclerosis, Relapsing-RemittingQuality of LifeAdultAtrophyDisease ProgressionFemaleGray MatterHumansMagnetic Resonance ImagingMaleMiddle AgedNeuropsychological Testscortical thicknessdemyelinating diseasemental healthneurodegenerative disease

Identifiers

PMID41272984
PMCPMC12638440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.